Legal & General Group PLC Xeris Biopharma Holdings, Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 210,843 shares of XERS stock, worth $640,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210,843
Previous 210,843
-0.0%
Holding current value
$640,962
Previous $600,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding XERS
# of Institutions
141Shares Held
59.9MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$31.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$23.6 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$15.5 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$10.6 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$10.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $413M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...